mogamulizumab-kpkc
Drug Details
- Generic Name
- mogamulizumab-kpkc
- Brand Names
- POTELIGEO
- Application Number
- BLA761051
- Sponsor
- Patheon Italia S.p.A.
- NDC Codes
- 2
- Dosage Forms
- INJECTION
- Routes
- INTRAVENOUS
- Active Ingredients
- MOGAMULIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy. POTELIGEO is a CC chemokine receptor type 4 (CCR4)-directed monoclonal antibody indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides or Sézary syndrome after at least one prior systemic therapy ( 1 ).